High Mobility Group 20B (HMG20B) Peptid
HMG20B
Reaktivität: Human
Wirt: Synthetic
BP
Produktnummer ABIN2711692
Kurzübersicht für High Mobility Group 20B (HMG20B) Peptid (ABIN2711692)
Target
HMG20B
(High Mobility Group 20B (HMG20B))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP)
-
-
Produktmerkmale
- The peptide is used to block Anti-BRAF35 Antibody reactivity.
-
-
-
-
Applikationshinweise
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year.
-
Haltbarkeit
- 12 months
-
-
- HMG20B (High Mobility Group 20B (HMG20B))
-
Hintergrund
- BRAF35, HMGX2, HMGXB2, SMARCE1R, SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related, SMARCE1-related protein, BRCA2-associated factor 35, HMG box-containing protein 20B, HMG domain-containing protein 2, HMG domain-containing protein HMGX2, Sox-like transcriptional factor, Structural DNA-binding protein BRAF35
-
Gen-ID
- 10362
-
UniProt
- Q9P0W2
Target
-
Sie sind hier:
